Sem F. Rikken - Publications

The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMI.

Journal: American heart journal

Published: June 08, 2026

Patient characteristics of non-participants and reasons for non-participation in cardiac (tele)rehabilitation-a prospective analysis.

Journal: Frontiers in rehabilitation sciences

Published: March 31, 2026

The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMI.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Mass balance and metabolite profiling of 14C-Zalunfiban in humans following single-dose subcutaneous administration.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: December 02, 2025

Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels.

Journal: JACC. Advances

Published: December 16, 2024

Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: July 15, 2024

Prehospital tirofiban increases the rate of disrupted myocardial infarction in patients with ST-segment elevation myocardial infarction: insights from the On-TIME 2 trial.

Journal: European heart journal. Acute cardiovascular care

Published: March 13, 2024

Cardiac (tele)rehabilitation in routine clinical practice for patients with coronary artery disease: protocol of the REHAB + trial.

Journal: Frontiers in cardiovascular medicine

Published: February 16, 2024

Optimizing Antiplatelet Pretreatment in STEMI: The Crucial Role of Timing and Agent Selection.

Journal: JACC. Cardiovascular interventions

Published: January 24, 2024

Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).

Journal: Journal of the American Heart Association

Published: December 08, 2023

Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.

Journal: American heart journal

Published: December 19, 2022

Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.

Journal: Thrombosis and haemostasis

Published: September 08, 2022